Browse > Article
http://dx.doi.org/10.5012/jkcs.2010.54.4.363

Molecular Modeling Study on Morphine Derivatives Using Density Functional Methods and Molecular Descriptors  

Cotua, Jose (Grupo de Investigacion Max Planck, Universidad del Atlantico, Facultad de Quimica y Farmacia)
Cotes, Sandra (Grupo de Investigacion en Quimica y Biologia, Universidad del Norte, Departamento de Quimica y Biologia)
Castro, Pedro (Grupo de Investigacion Max Planck, Universidad del Atlantico, Facultad de Quimica y Farmacia)
Castro, Fernando (Grupo de Investigacion Max Planck, Universidad del Atlantico, Facultad de Quimica y Farmacia)
Mora, Liadys (Grupo de Investigacion Max Planck, Universidad del Atlantico, Facultad de Quimica y Farmacia)
Publication Information
Journal of the Korean Chemical Society / v.54, no.4, 2010 , pp. 363-373 More about this Journal
Abstract
Computational studies were carried out on the opiates morphine, heroin, codeine, pentazocine, and buprenorphine, under the density functional theory. The geometric parameters of the pharmacophore and substituents were evaluated at the B3LYP/6-31+G(d) level of theory. The electronic structure calculations were performed using the same hybrid functional at the B3LYP/6-311++G (d,p) level of theory. The atomic charges were obtained by Mulliken population analysis. Given the reported biological activity, calculated partition coefficients, and electronic and geometric analysis, pentazocine and buprenorphine were chosen as models for proposed analogues. These analogues were then studied and compared with the model molecules. The study reveals that the geometry and electronic structure of the pharmacophore remains consistent in the presence of different substituents. Because the proposed analogues preserve the studied properties of the model molecules, it is likely that these analogues display biological activity.
Keywords
Opiates; DFT calculations; Pharmacophore;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
Times Cited By SCOPUS : 0
연도 인용수 순위
1 Madronero, R. Quimica Medica: Metodos fundamentales en la busqueda de nuevos farmacos; Editorial Alambra: Madrid, 1980; pp 298-332.
2 Jacobson, A. E.; May, E. L.; J, S. L. J. Med. Chem. 1970, 13, 1061.   DOI
3 Gago, F. Metodos Computacionales de Modelado Molecular y Diseno de Farmacos; Madrid, 1994; pp 253-327.
4 Loew, H.; Berkowitz, S. J. Med. Chem. 1975, 18, 656.   DOI
5 Loew, H.; Berkowitz, S. J. Med. Chem. 1978, 25, 101.
6 Loew, H.; Berkowitz, S.; Burt, K. NIDA Research Monograph 22; Editorial Advisory Board: Maryland, 1978; pp 278-310.
7 Chun, S.; Lee, J. Y.; Ro, S. G.; Ki, K. W.; Kim, Y.; Yoon, C. J. Bull. Korean Chem. Soc. 2008, 9, 656.
8 Schlegel, B. H. J. Comput. Chem. 2003, 24, 1514.   DOI
9 Canfield, D.; Barrick, J.; Giessen, B. Acta Crystallogr. Sect. C: Cryst. Struct. Commun. 1987, 43, 977.   DOI
10 Canfield, D.; Barrick, J.; Giessen, B. C. Acta Crystallogr. Sect. B: Struct. Sci. 1979, 35, 2806.   DOI
11 Mejeste, R. J.; Poindexter, D.; Jones, J.; Klein, C. L. Acta Crystallographica Section C: Foundations of Crystallography 1994, 50, 1633.   DOI   ScienceOn
12 Kratochvil, B.; Husak, M.; Bulfj, P.; Jegorov, A. Collect. Czech. Chem. Commun. 1994, 59, 2472.   DOI
13 Felizola, M.; Villar, H.; Loew, H. Bioorg. Med. Chem. 2001, 9, 69.   DOI
14 Vernon, B.; Duchamp, D. J.; Chritoffersen, R. NIDA Research Monograph 22; Editorial Advisory Board: Maryland, 1978; pp 218-242.
15 Gomez, J.; Gerli, L.; Hurtado, M. J. Chil. Chem. Soc. 2004, 49, 307.
16 Frenking, G.; Loew, H.; Lawson, J. NIDA Research Monograph 75; Editorial Advisory Board: Maryland, 1986; pp 53-55.
17 Kane, B. E.; Svensson, B.; Ferguson, D. M. The AAPS Journal. 2006, 8, E126-E137.   DOI
18 Escalona, J.; Carrasco, R.; Padron, J. Introduccion al Diseno Racional de Farmacos; Editorial Universitaria: Ciudad de la Habana, 2008; Vol. 2, pp 38-40.
19 Fang, F. J.; Ke, J. Z.; Pu, S. Z.; Jian, Z. Bull. Korean Chem. Soc. 2006, 27, 7.
20 Svesson, M.; Humbel, S.; Froese, R.; Matsura, T.; Sieber, S.; Murokuma, K. J. Phys. Chem. 1996, 100, 19357.   DOI
21 Sednicer, D. J. Chem. Educ. 1989, 718.
22 Gaussian 03W, Revision D.01, Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.; Robb, M. A.; Cheeseman, J. R.; Montgomery, J. A.; Jr., T. V.; Kudin, K. N.; Burant, J. C.; Millam, J. M.; Iyengar, S. S.; Tomasi, J.; Barone, V.; Mennucci, B.; Cossi, M.; Scalmani, G.; Rega, N.; Petersson, G. A.; Nakatsuji, H.; Hada, M.; Ehara, M.; Toyota, K.; Fukuda, R.; Hasegawa, J.; Ishida, M.; Nakajima, T.; Honda, Y.; Kitao, O.; Nakai, H.; Klene, M.; Li, X.; Knox, J. E.; Hratchian, H. P.; Cross, J. B.; Bakken, V.; Adamo, C.; Jaramillo, J.; Gomperts, R.; Stratmann, R. E.; Yazyev, O.; Austin, A. J.; Cammi, R.; Pomelli, C.; Ochterski, J. W.; Ayala, P. Y.; Morokuma, K.; Voth, G. A.; Salvador, P.; Dannenberg, J. J.; Zakrzewski, V. G.; Dapprich, S.; Daniels, A. D.; Strain, M. C.; Farkas, O.; Malick, D. K.; Rabuck, A. D.; Raghavachari, K.; Foresman, J. B.; Ortiz, J. V.; Cui, Q.; Baboul, A. G.; Clifford, S.; Cioslowski, J.; Stefanov, B. B.; Liu, G.; Liashenko, A.; Piskorz, P.; Komaromi, I.; Martin, R. L.; Fox, D. J.; Keith, T.; Al-Laham, M. A.; Peng, C. Y.; Nanayakkara, A.; Challacombe, M.; Gill, P. M. W.; Johnson, B.; Chen, W.; Wong, M. W.; Gonzalez, C.; J. A. Pople, Gaussian, Inc., Wallingford CT, 2004.
23 Gylbert, L. Acta Crystallogr. Sect. B: Struct. Sci. 1973, 29, 1630.   DOI
24 Florez, J. Farmacos Analgesicos Opiodes; Internacional de ediciones y publicaciones: Madrid, 1998; Vol. 7, pp 4908-4919.
25 Graham, P. An Introduction to Medicinal Chemistry; Oxford University Press: New York, 1995; pp 245-280.
26 Silverman, B. The Organic Chemistry of Drug Design and Drug Action; Academic Press: San Diego, 1992; pp 11-13.
27 De Pascual, B.; Gallego, J.; Ortiz, A.; Gago, F. J. Med. Chem. 1996, 39, 4810.   DOI
28 Schug, A.; Fisher, B.; Verna, A.; Merlitz, H.; Wenzel, W.; Schoen, S. Adv. Eng. Mater. 2005, 7, 1005.   DOI
29 Baker, D.; Sali, A. Science 2001, 294, 93.   DOI
30 Gouda, H., et al. Biochemistry 1992, 40, 9665
31 Mayor, U., et al. Nature 2003, 421, 863.   DOI